This product (CAS:25984-63-8) is an intermediate of non - buxostat.Purity over 99%.Application of febuxostat: it is a new non-purine highly effective and selective xanthine oxidase (XO) inhibitor, which is an effective substitute for allopurinol allergy or intolerance to gout, especially for patients with renal insufficiency.
The English name
0mmHg at 25°C
320.394ºC at 760 mm Hg
Jinan lead pharmaceutical technology co., Ltd., founded in 2013, located at no.2766 yingxiu, high-tech zone, jinan.We are professional to r&d, production and sales of pharmaceutical raw materials and intermediates. in jinan high-tech zone has our research and development center, and the production base is located in ulanqab, Inner Mongolia. The factory design has 6 production workshops, covering an area of 150 mu.Up to now, we have passed the supplier audit of many domestic pharmaceutical enterprises and world-class pharmaceutical enterprises.
Product quality assurance
Our production factory is mainly engaged in pharmaceutical intermediates, raw materials and part of the contract custom processing of high-tech manufacturing enterprises. We use advanced equipment and facilities, and has a sound quality system, the production of products must through strict quality control. In addition, we have a professional service staff to serve for our customers.
Our business philosophy is "integrity, cooperation, win-win".Good cooperation will be an inexhaustible driving force for our common progress .
All products are in stock, and it takes 4-6 weeks to prepare for large quantities. For details, please consult:
Product specialist: Celia Zhang
1) Q:What is your company’s payment?
A: Full payment before shipment.
2) Q:When can we expect delivery?
A: A small amount of goods are in stock, large amount needs 4-6 weeks of delivery
3) Q: Is there any COA for quality assurance
A: Yes, of course.